Stock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration

Stock Track11-12

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) saw its stock soar 5.28% in intraday trading on Tuesday, following a positive analyst report from H.C. Wainwright. The surge in stock price comes as investors react to the reiterated Buy rating and a bullish price target set by analyst Patrick Trucchio.

H.C. Wainwright's Trucchio maintained a Buy rating on Mind Medicine, setting an ambitious price target of $55.00. This target suggests significant upside potential for the psychedelic medicine company's stock, likely contributing to the heightened investor interest and subsequent price increase.

Analyst ratings often play a crucial role in shaping investor sentiment, particularly for biotech companies like Mind Medicine that are working on innovative treatments. The reiterated Buy rating from a respected firm like H.C. Wainwright may be interpreted as a vote of confidence in MindMed's research pipeline and overall business strategy, prompting both institutional and retail investors to take bullish positions in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182264596?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 03:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182264596","market":"sg","top_or_hot":-1,"title":"Stock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration","media":"Stock Track","content":"<p>Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) saw its stock soar 5.28% in intraday trading on Tuesday, following a positive analyst report from H.C. Wainwright. The surge in stock price comes as investors react to the reiterated Buy rating and a bullish price target set by analyst Patrick Trucchio.</p>\n\n<p>H.C. Wainwright's Trucchio maintained a Buy rating on Mind Medicine, setting an ambitious price target of $55.00. This target suggests significant upside potential for the psychedelic medicine company's stock, likely contributing to the heightened investor interest and subsequent price increase.</p>\n\n<p>Analyst ratings often play a crucial role in shaping investor sentiment, particularly for biotech companies like Mind Medicine that are working on innovative treatments. The reiterated Buy rating from a respected firm like H.C. Wainwright may be interpreted as a vote of confidence in MindMed's research pipeline and overall business strategy, prompting both institutional and retail investors to take bullish positions in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-12 03:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) saw its stock soar 5.28% in intraday trading on Tuesday, following a positive analyst report from H.C. Wainwright. The surge in stock price comes as investors react to the reiterated Buy rating and a bullish price target set by analyst Patrick Trucchio.</p>\n\n<p>H.C. Wainwright's Trucchio maintained a Buy rating on Mind Medicine, setting an ambitious price target of $55.00. This target suggests significant upside potential for the psychedelic medicine company's stock, likely contributing to the heightened investor interest and subsequent price increase.</p>\n\n<p>Analyst ratings often play a crucial role in shaping investor sentiment, particularly for biotech companies like Mind Medicine that are working on innovative treatments. The reiterated Buy rating from a respected firm like H.C. Wainwright may be interpreted as a vote of confidence in MindMed's research pipeline and overall business strategy, prompting both institutional and retail investors to take bullish positions in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNMD","symbol_name":"Mind Medicine (MindMed) Inc.","start_time":0,"source_url":"","article_id":"1182264596","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182264596","pubTimestamp":1762887626,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) saw its stock soar 5.28% in intraday trading on Tuesday, following a positive analyst report from H.C. Wainwright. The surge in stock price comes as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc."},"translate_title":"股票追踪|Mind Medicine(MindMed)跟随H.C.飙升5.28%温赖特重申买入评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNMD":1},"content_text":"Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) saw its stock soar 5.28% in intraday trading on Tuesday, following a positive analyst report from H.C. Wainwright. The surge in stock price comes as investors react to the reiterated Buy rating and a bullish price target set by analyst Patrick Trucchio.\nH.C. Wainwright's Trucchio maintained a Buy rating on Mind Medicine, setting an ambitious price target of $55.00. This target suggests significant upside potential for the psychedelic medicine company's stock, likely contributing to the heightened investor interest and subsequent price increase.\nAnalyst ratings often play a crucial role in shaping investor sentiment, particularly for biotech companies like Mind Medicine that are working on innovative treatments. The reiterated Buy rating from a respected firm like H.C. Wainwright may be interpreted as a vote of confidence in MindMed's research pipeline and overall business strategy, prompting both institutional and retail investors to take bullish positions in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182264596","isCrawlerRequest":true}